NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase N/A
NCT01887548 Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients Status UNKNOWN Phase NA
NCT01874015 Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease Status UNKNOWN Phase PHASE1
NCT01860846 Anti-Tumor Necrosis Factor (TNF) Treatments, Work Productivity and Quality of Life in Crohn's Disease Status COMPLETED Phase N/A
NCT01847170 Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease Status COMPLETED Phase PHASE1
NCT01836289 High-dose Cyclophosphamide for Severe Refractory Crohn Disease Status WITHDRAWN Phase PHASE1/PHASE2
NCT01828190 The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha Blockers Status COMPLETED Phase NA
NCT01827631 Single and Repeat Dose Pharmacokinetic Study of GSK1605786 in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01826188 Combined THC and CBD Drops for Treatment of Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01823042 The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD) Status UNKNOWN Phase NA
NCT01823029 Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia Status COMPLETED Phase NA
NCT01820247 Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission Status UNKNOWN Phase NA
NCT01817972 Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease Status UNKNOWN Phase PHASE3
NCT01813500 Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients Status COMPLETED Phase N/A
NCT01810185 Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease Status WITHDRAWN Phase PHASE2